MBD4 Interacts With and Recruits USP7 to Heterochromatic Foci

被引:14
|
作者
Meng, Huan [1 ,2 ]
Harrison, David J. [3 ]
Meehan, Richard R. [1 ]
机构
[1] Univ Edinburgh, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland
[2] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang 110001, Peoples R China
[3] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland
基金
英国生物技术与生命科学研究理事会;
关键词
MBD4; UHRF1; USP7; HETEROCHROMATIN REPLICATION AND FORMATION; UBIQUITIN-SPECIFIC PROTEASE; DNA METHYLATION; UHRF1; REPAIR; DOMAIN; DNMT1; NP95; DEFICIENCY; PROTEINS; MED1;
D O I
10.1002/jcb.25001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MBD4 is the only methyl-CpG binding protein that possesses a C-terminal glycosylase domain. It has been associated with a number of nuclear pathways including DNA repair, DNA damage response, the initiation of apoptosis, transcriptional repression, and DNA demethylation. However, the precise contribution of MBD4 to these processes in development and relevant diseases remains elusive. We identified UHRF1 and USP7 as two new interaction partners for MBD4. Both UHRF1, a E3 ubiquitin ligase, and USP7, a de-ubiquinating enzyme, regulate the stability of the DNA maintenance methyltransferase, Dnmt1. The ability of MBD4 to directly interact with and recruit USP7 to chromocenters implicates it as an additional factor that can potentially regulate Dnmt1 activity during cell proliferation. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:476 / 485
页数:10
相关论文
共 27 条
  • [21] USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4/PI3K/AKT axis
    Wang, Ying
    Luo, Xia
    Wu, Nayiyuan
    Liao, Qianjin
    Wang, Jing
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (01) : 97 - 107
  • [22] The role of the deubiquitinase USP7 and the E3/E4 ubiquitin ligase complex ITCH/UBE4B in the regulation of cell death in neuroblastoma
    Le Clorennec, Christophe
    Sampaio, Carla
    Zage, Peter E.
    CANCER RESEARCH, 2024, 84 (06)
  • [23] Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy
    Zhuang, Zhen
    Miao, Yu-Ling
    Song, Shan-Shan
    Leng, Guang-Tong
    Zhang, Xiao-Fei
    He, Qian
    Ding, Jian
    He, Jin-Xue
    Yang, Chun-Hao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 277
  • [24] Novel Thiophene Thioglycosides Substituted with the Benzothiazole Moiety: Synthesis, Characterization, Antiviral and Anticancer Evaluations, and NS3/4A and USP7 Enzyme Inhibitions
    Azzam, Rasha A.
    Gad, Nagwa M.
    Elgemeie, Galal H.
    ACS OMEGA, 2022, 7 (40): : 35656 - 35667
  • [25] DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1
    Miao, Ying
    Zhang, Tingting
    Guan, Mingcheng
    Zhao, Qian
    Zhang, Renxia
    Liu, Xuyi
    Ma, Tianrun
    Ren, Tengfei
    Zheng, Zhijin
    He, Wei
    Tian, Wanying
    Cui, Qun
    Zhai, Xingyu
    Zuo, Yibo
    Zhu, Hong
    Zheng, Hui
    Yuan, Yukang
    MBIO, 2024, 15 (03):
  • [26] USP7 Inhibition Alleviates H2O2-Induced Injury in Chondrocytes via Inhibiting NOX4/NLRP3 Pathway
    Liu, Gang
    Liu, Qingbai
    Yan, Bin
    Zhu, Ziqiang
    Xu, Yaozeng
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [27] Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors
    Li, Peng
    Liu, Ying
    Yang, Hua
    Liu, Hong-Min
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 216